Skip to main content

Year: 2021

Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base

Bavarian Nordic to initiate Phase 3 with RSV vaccine candidate in first half of 2022 subject to a successful equity capital raise EBITDA expectations for 2021 slightly lowered, as Phase 3 preparations are now being intensified COPENHAGEN, Denmark, December 6, 2021 – Bavarian Nordic A/S (OMX: BAVA) a fully integrated vaccines company, formally announces its commitment to initiate a Phase 3 clinical trial of its RSV vaccine candidate, MVA-BN® RSV. Bavarian Nordic intends to fund the trial through an equity raise, of up to 10% of its registered share capital. Strategic update on RSV vaccine candidateBavarian Nordic remains committed to the vision of becoming a leading pure-play vaccine company by 2025 through a combination of organic growth and/or acquisitions, and MVA-BN RSV holds the potential to become a key contributor to this vision....

Continue reading

Albioma : Albioma’s continuous progress in CSR rewarded by the Gaïa ESG Rating

PRESS Release Paris La Défense, 6 December, 2021 Albioma’s continuous progress in CSR rewarded by the Gaïa ESG Rating Albioma is proud to announce that it has been included in the top third of the national ranking of the Gaïa Index, the benchmark for ESG (environment, social and governance) ratings, which evaluated 390 French mid-cap listed stocks in 2021, up from 230 French stocks in 2020. A member of the index since 2014, Albioma was awarded a score of 73/100, which has been steadily increasing over the past two years, with a significant rise of 7 points. Albioma is thus ranked above the average of the national benchmark, evaluated at 59/100. Already distinguished for several years by V.E. (formerly Vigeo Eiris), another reference in terms of SRI (socially responsible investment) indices, the Gaïa ranking is the reward for Albioma’s...

Continue reading

The first multi-buyer Green CPPA in Europe

Ten companies, customers of LCL, will be able to accelerate their energy transition by directly accessing the green electricity produced by a new 56-megawatt photovoltaic power plant developed by Voltalia for this purpose Ten companies are joining this innovative CPPA, designed jointly by Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, and LCL, the leading bank for small and medium-sized companies which is committed to the energy transition of its customers. Through this CPPA, these 10 companies, along with LCL, will share 100% of the electricity produced by a new photovoltaic power plant over the next 20 years. Voltalia will develop and operate this 56 megawatt power plant located in the south of France, which is also home to a pastoral activity that promotes local development. For its...

Continue reading

Lithium-ion Battery Recycling Market to rise at CAGR of 21.43% through 2030 – Report by Market Research Future (MRFR)

New York, Dec. 06, 2021 (GLOBE NEWSWIRE) — Lithium-ion Battery Recycling Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Lithium-ion Battery Recycling Market  Information Report by End Use(Automotive, and Non-automotive [Industrial, Power, and Marine]),by Battery Chemistry (Lithium-nickel Manganese Cobalt (Li-NMC), Lithium-iron Phosphate (LFP), Lithium-manganese Oxide (LMO), Lithium-titanate Oxide (LTO), and Lithium-nickel Cobalt Aluminum Oxide (NCA)), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) – Forecast till 2030” Market Research Future’s Review on Lithium-ion Battery Recycling Market The global lithium-ion battery recycling market will touch USD 24.31 billion at a 21.43% CAGR by 2030, states the latest Market Research Future...

Continue reading

Intertrust and CSC agree on recommended all-cash offer of EUR 20.00 per share

JOINT PRESS RELEASE This is a joint press release by Intertrust N.V. (“Intertrust” or the “Company”) and Corporation Service Company (“CSC” or the “Offeror”) pursuant to the provisions of Section 4, paragraphs 1 and 3, Section 5, paragraph 1 and Section 7, paragraph 4 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft, the “Decree”) in connection with the intended recommended public offer (the “Offer”) by the Offeror for all the issued and outstanding ordinary shares in the capital of Intertrust. This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Intertrust. Any offer will be made only by means of an offer memorandum (the “Offer Memorandum”) approved...

Continue reading

MRHB DeFi Expands Asia Presence with Strategic Investment from Sinofy Group

Melbourne, Australia, December 3, 2021 — The world’s first inclusive and ethical DeFi ecosystem platform MRHB DeFi has received a strategic investment from Sinofy Group, a tech consulting management firm headquartered in Shanghai. Sinofy supports revolutionary tech companies to help them gain prominence in the world’s most digitally connected regions — China and Southeast Asia. A Partnership that goes beyond financial investment The investment includes a strategic partnership which sees MRHB DeFi join hands with Sinofy to fulfil the former’s vision of bringing an ethical, community-first focus to the world of decentralized finance. Sinofy Co-founder and angel investor Amirsan Roberto has taken the partnership a step further and joined the halal DeFi ecosystem startup as the Head of Investments and Partnerships. “Joining as...

Continue reading

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions Affordable and small, instrument-free testing kit enables convenient use for healthcare professionals at different point of care locations and in resource-limited settings The test works seamlessly with NAVIFY® Pass, Roche’s digital solution that allows individuals and healthcare professionals to immediately store, display, and share their COVID-19 test results and vaccine status through a unique data matrixBasel, 6 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the...

Continue reading

Results of EssilorLuxottica’s mandatory public offer for GrandVision shares

Results of EssilorLuxottica’s mandatory public offer for GrandVision shares • Acceptance Period ended 3 December 2021 (at 17:40 hours CET)• 13.06% of the Shares have been tendered under the Offer during the Acceptance Period• Including the 86.67% of the Shares already held by the Offeror, the Offeror will hold a total interest of 99.73%• Settlement of the Offer will take place on 8 December 2021, at which date the Offer Price of Euro 28.42 per Share will be paid• Remaining Shares can be tendered during the Post-Acceptance Period, commencing on 7 December 2021 at 09:00 hours CET and ending on 20 December 2021 at 17:40 hours CET Charenton-le-Pont, France and Schiphol, the Netherlands (6 December, 2021 – 7:00am CET) – With reference to the press release of 7 October 2021 by EssilorLuxottica S.A. (the “Offeror“) and GrandVision N.V. (“GrandVision”)...

Continue reading

EssilorLuxottica : Results of EssilorLuxottica’s mandatory public offer for GrandVision shares

Results of EssilorLuxottica’s mandatory public offerfor GrandVision shares  Acceptance Period ended 3 December 2021 (at 17:40 hours CET) 13.06% of GrandVision shares have been tendered under the Offer during the Acceptance Period Including the 86.67% interest already held by the Offeror, the Offeror will hold a total interest of 99.73% Settlement of the Offer will take place on 8 December 2021, at which date the Offer Price of Euro 28.42 per Share will be paid Remaining Shares can be tendered during the Post-Acceptance Period, commencing on 7 December 2021 at 09:00 hours CET and ending on 20 December 2021 at 17:40 hours CETCharenton-le-Pont, France and Schiphol, the Netherlands (6 December, 2021 – 7:00am CET) – With reference to the press release of 7 October 2021 by EssilorLuxottica S.A. (the “Offeror“) and GrandVision N.V. (“GrandVision”)...

Continue reading

Duolingo Reveals the “Most 2021 Phrase” and Launches Second Global Language Report

End of year campaign showcases most popular language courses, phrases and reasons people use the world’s leading mobile language learning platform PITTSBURGH, Dec. 06, 2021 (GLOBE NEWSWIRE) — Duolingo (NASDAQ: DUOL), the world’s #1 language learning platform, this week revealed the “Most 2021 Phrase” which is “I’m mentally exhausted”. Duolingo selected this phrase, found in its Japanese course, to reflect the tone and overall feeling of the year in which we witnessed record-setting burnout and fatigue induced by the ongoing pandemic. Alongside the “Most 2021 Phrase”, Duolingo also launched the company’s second global Language Report, which examines the latest language trends and learner behaviors based on data from over 500 million Duolingo learners around the globe who have downloaded the app. In 2021, over 700 million hours were...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.